PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition

Cancer immunotherapy involves blocking the interactions between the PD-1/PD-L1 immune checkpoints with antibodies. This has shown unprecedented positive outcomes in clinics. Particularly, the PD-L1 antibody therapy has shown the efficiency in blocking membrane PD-L1 and efficacy in treating some adv...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Frontiers in immunology Jg. 10; S. 2022
Hauptverfasser:	Wu, Yilun, Chen, Weiyu, Xu, Zhi Ping, Gu, Wenyi
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland Frontiers Media S.A 27.08.2019
Schlagworte:	cancer immunotherapy cellular PD-L1 distribution gene silencing Immunology PD-1/PD-L1 immune checkpoint PD-L1 regulation signaling pathway inhibitor cancer immunotherapy gene silencing signaling pathway inhibitor PD-L1 regulation combination therapy PD-1/PD-L1 immune checkpoint cellular PD-L1 distribution
ISSN:	1664-3224, 1664-3224
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!